CMS has announced a deferral of federal Medicaid matching funds to California, marking only the second time in Medicaid's 60-year history such action has been taken. Vice President J.D. Vance announced the deferral at a White House press conference, following a similar announcement on February 25. Federal financial participation deferrals represent CMS's most severe enforcement tool and typically indicate suspected fraud, waste, or abuse requiring state corrective action. The action creates immediate cash flow implications for California's Medicaid program and may signal broader federal enforcement priorities affecting managed care oversight.
Managed Care · Finance
The National Health Law Program published guidance for states on mitigating administrative challenges created by the One Big Beautiful Bill Act (OBBBA). The legislation imposes more frequent renewals, work requirements, and additional eligibility checks that will increase strain on state Medicaid agencies and enrollees, particularly individuals with disabilities. NHeLP recommends states prepare operational "landing pads" to prevent coverage disruptions as these changes take effect. The guidance is critical for managed care organizations whose enrollment stability and member outreach will be directly affected by states' administrative capacity during implementation.
Managed Care · LTSS
CMS published a proposed rule on May 22, 2026, that would impose payment limits on additional state directed payments in Medicaid managed care and establish new limits for targeted fee-for-service payments. The rule draws authority from section 71116 of H.R. 1 (the "One Big Beautiful Bill Act") and presidential directives. State directed payments allow states to require managed care organizations to adopt specific provider payment arrangements, and new limits could constrain state flexibility in setting enhanced reimbursement rates for hospitals, nursing facilities, and other providers. The proposal would affect how states design rate strategies and could require MCOs to renegotiate provider contracts if existing SDP arrangements exceed new federal limits.
Managed Care · Finance
CMS Administrator Dr. Mehmet Oz, with support from Vice President J.D. Vance, initiated a two-pronged action against Minnesota's Medicaid program on January 6, threatening to withhold $515 million in federal matching funds. The action centers on alleged fraud concerns within the state's Medicaid program. The article suggests this fiscal enforcement action may be reaching resolution. Minnesota managed care plans and state officials face potential significant federal funding disruptions pending CMS review of state compliance with program integrity requirements.
Managed Care · Finance
The National Health Law Program has begun publishing a weekly series addressing Medicaid work requirements and implementation issues under the One Big Beautiful Bill Act. The resource aims to help advocates monitor federal and state agency actions as policy changes roll out. The series will provide practical guidance on emerging compliance and operational issues. This matters for MCOs because work requirements typically impose new eligibility verification, enrollment monitoring, and reporting obligations on plans under contract with states implementing these policies.
Managed Care
Medicaid and CHIP enrollment among children declined by 2 million between January 2025 and April 2026, according to state-by-state enrollment data. The drop suggests a rising child uninsured rate during this period. The enrollment decline affects managed care organizations through reduced membership and capitation revenue, particularly in states with high CHIP and Medicaid managed care penetration. Plans should monitor monthly enrollment reports and assess financial impacts from membership losses in pediatric populations.
CHIP · Managed Care
On May 1, 2026, OIG issued Advisory Opinion 26-09 addressing a pediatric dental and orthodontic provider's proposal to offer free orthodontic treatment to one patient annually at each of its three practice locations. The opinion provides guidance on how such charitable arrangements may comply with federal anti-kickback statute and beneficiary inducement provisions. For Medicaid managed care dental plans and MCOs with dental benefits, this opinion clarifies acceptable parameters for provider charitable care arrangements that could affect network adequacy and access strategies, particularly for orthodontic services where cost barriers are common.
Dental · Managed Care
The Trump administration's most favored nation (MFN) pricing agreements with pharmaceutical manufacturers remain under scrutiny as implementation details emerge. These agreements aim to tie U.S. drug prices to lower international reference prices. Medicaid managed care organizations may see indirect effects through pharmacy benefit design and supplemental rebate negotiations, though the agreements primarily target Medicare Part B and Part D. The timing and scope of implementation remain uncertain, creating planning challenges for health plans managing pharmacy benefits across multiple programs.
Pharmacy · Managed Care
CMS released the FY 2027 Inpatient Prospective Payment System proposed rule updating Medicare hospital payment rates, uncompensated care payments, and graduate medical education residency program definitions. The rule expands the CJR-X joint replacement payment model and solicits comment on new quality measures. While IPPS primarily governs Medicare fee-for-service hospital payments, changes to quality measures and payment methodologies often influence Medicaid managed care quality programs and hospital contract negotiations. The comment period timeline was not specified in the excerpt.
Managed Care
CMS has temporarily halted new provider enrollment for home health and hospice services in Medicare, though specific details on duration and scope are not provided in the brief announcement. The enrollment pause likely reflects heightened scrutiny of fraud vulnerabilities in these sectors, which have been subjects of recent OIG investigations. Medicaid managed care organizations with delegated or integrated home health and hospice networks should monitor whether similar restrictions emerge in their contracts or state programs, particularly for dual-eligible populations where Medicare enrollment status affects network adequacy.
LTSS · Managed Care
The FDA has relaxed regulatory oversight of wellness wearable devices, allowing blood pressure monitoring technology to enter the market without clinical validation. This policy shift enables consumer devices with unverified accuracy to proliferate, potentially affecting remote patient monitoring programs that Medicaid managed care organizations use for hypertension management and chronic disease monitoring. MCOs relying on wearable data for care management and quality metrics should assess whether their contracted devices meet clinical accuracy standards, particularly for programs serving members with cardiovascular conditions.
Managed Care
On May 21, 2026, USCIS issued a policy memo restricting adjustment of status applications, requiring applicants to demonstrate extraordinary circumstances to obtain lawful permanent residence without consular processing. The memo recharacterizes adjustment of status as discretionary relief rather than a routine pathway. This change affects healthcare organizations that sponsor foreign-born clinical staff and may complicate workforce planning for Medicaid managed care plans that rely on immigrant physicians, nurses, and behavioral health providers in shortage areas. Plans should review existing sponsorship pipelines and anticipate longer credentialing timelines.
Managed Care · Behavioral Health
CMS has rechartered the Medicare Advisory Panel on Clinical Diagnostic Laboratory Tests and appointed five new members. The panel will meet July 14-15, 2026, to advise HHS and CMS on clinical diagnostic laboratory test issues under Medicare. While focused on Medicare, decisions on laboratory test coverage and payment often influence Medicaid managed care plan policies for diagnostic services, particularly for dual-eligible populations and carve-in lab benefits. State Medicaid programs frequently align lab fee schedules and coverage criteria with Medicare determinations.
Managed Care